Regeneron Pharma(REGN.US)

Last Updated 19:00:00 ET
longbridge loading

Google Reportedly Teams Up with Blackstone to Establish New AI Cloud Company

AASTOCKS News·
US
BX
-0.72%
US
GGLL
+0.10%
US
CLOU
+2.26%
AASTOCKS News·
US
BX
-0.72%
US
GGLL
+0.10%
US
CLOU
+2.26%

Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates

Pharmaceutical Technology·
US
REGN
-9.82%
Pharmaceutical Technology·
US
REGN
-9.82%

18:24 ETRegeneron Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Regeneron Pharmaceuticals (REGN)

prnewswire·
US
REGN
-9.82%
US
ARKG
-0.14%
US
VHT
+0.30%
prnewswire·
US
REGN
-9.82%
US
ARKG
-0.14%
US
VHT
+0.30%

Health Care Up on Rotation Into Lagging Sectors — Health Care Roundup

MorningStar·
US
REGN
-9.82%
US
PBE
-0.58%
US
XLV
+0.43%
MorningStar·
US
REGN
-9.82%
US
PBE
-0.58%
US
XLV
+0.43%

Equity Markets Mixed as Trump Aborts Plan to Attack Iran

fidelity·
US
D
+9.44%
US
NVDL
-2.64%
US
NVDX
-2.72%
fidelity·
US
D
+9.44%
US
NVDL
-2.64%
US
NVDX
-2.72%

Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.

Barchart Option·
US
REGN
-9.82%
Barchart Option·
US
REGN
-9.82%

Regeneron stock drops double digits on oncology trial failure

Invezz·
US
REGN
-9.82%
Invezz·
US
REGN
-9.82%
© 2026 Longbridge｜Disclaimer